机译:少年异常的子宫出血比急性静脉血栓栓塞治疗的妇女的妇女比华法林
Department of Thrombosis and HemostasisLeiden University Medical CenterLeiden the Netherlands;
Department of Internal MedicineHospital Garcia de OrtaAlmada Portugal;
Boehringer Ingelheim GmbH &
Co KGIngelheim am Rhein Germany;
Boehringer Ingelheim GmbH &
Co KGIngelheim am Rhein Germany;
Department of Thrombosis and HemostasisLeiden University Medical CenterLeiden the Netherlands;
abnormal uterine bleeding; anticoagulation; bleeding; dabigatran; direct oral anticoagulants;
机译:少年异常的子宫出血比急性静脉血栓栓塞治疗的妇女的妇女比华法林
机译:对埃西哥汉或华法林进行静脉血栓栓塞治疗的生殖年龄妇女异常阴道出血:Hokusai-VTE VTE研究的后HOC分析
机译:患有贫血血栓栓塞治疗的妇女异常阴道出血,治疗Apixaban或Warfarin
机译:评价急性静脉血栓栓塞症状的症状
机译:当前抗凝治疗的成本效果与长期华法林抗凝治疗之前的CYP2C9和VKORC1遗传检测的关系:基于静脉血栓栓塞自然史的离散事件模拟模型的实现。
机译:依多沙班或华法林治疗静脉血栓栓塞的育龄妇女阴道异常出血:Hokusai-VTE研究的事后分析
机译:Dabigatran对华法林对血栓血栓栓塞患者的疗效:来自Re-Pocke®,重新封面™II和Re-Medy™的调查结果